Centre Hospitalier De Chauny
- Address
- 94 Rue Anciens Combattants Afn Tom, 02300 Chauny, France
Centre Hospitalier De Chauny - Oncology & Pulmonary Research
Centre Hospitalier De Chauny is a distinguished clinical research center with specialized expertise in advanced lung cancer therapeutics and pulmonary infectious diseases. The center demonstrates particular strength in evaluating novel immunotherapy combinations and targeted maintenance therapies for patients with metastatic non-small cell lung cancer, contributing significantly to the advancement of personalized cancer treatment protocols.
- Non-Small Cell Lung Cancer (NSCLC) immunotherapy trials, including pembrolizumab, atezolizumab, nivolumab, and combination regimens
- Maintenance therapy strategies with PARP inhibitors (olaparib) and immune checkpoint inhibitors in metastatic lung cancer
- Mycobacterium avium complex pulmonary infections and macrolide antibiotic treatment optimization
- Metastatic colorectal cancer second-line therapies combining chemotherapy with targeted agents
The center's research portfolio reflects a comprehensive approach to stage IV lung cancer management, encompassing both squamous and non-squamous histologies, with special focus on elderly patient populations and progression-free survival optimization. Through participation in multicenter phase II and III clinical trials, Centre Hospitalier De Chauny contributes valuable data on treatment sequencing, maintenance strategies, and the efficacy of emerging immunotherapeutic combinations in advanced solid tumors.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier De Chauny
lock Showing 1 of 12 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial Comparing Azithromycin and Clarithromycin in Mycobacterium Avium Complex Pulmonary Disease Treatment | Centre Hospitalier Universitaire Amiens Picardie | Phase III | Recruiting | Feb 2018 | — |
IMP list
lock Showing 1 of 27 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 5 | Unknown | 2019-06-25 | 2024-07-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.